The American Health Council Selects Ruth Dapaah-Afriyie, Pharm.D., B.Pharm., BCACP, CDOE, CVDOE to Industry Board

NEXT STORY
ADMA Biologics Announces Pricing of Public Offering of Common Stock
PREV STORY
Terveystalo Plc: Changes in the Composition of Shareholders’ Nomination Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Corbus Pharmaceuticals Announces Acceptance of Three Abstracts for Presentation at EULAR 2018 Annual Meeting

- Data from Phase 2 one-year open-label extension of lenabasum in systemic sclerosis and ...

author_avatar
NASDAQ Market News

Roche’s Actemra/RoActemra becomes the first biologic therapy approved by the FDA for slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease, a rare, debilitating condition

author_avatar
NASDAQ Market News

Galera Therapeutics Announces Interim Data from Pilot Phase 1/2 Trial of GC4419 in Combination with Stereotactic Body Radiation Therapy Showed Improved Overall Survival in Patients with Locally Advanced Pancreatic Cancer

author_avatar
NASDAQ Market News